|1|Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment. (25719991)
Bressler S.B.... Melia M.
|2|The ocular hypotensive effect of saffron extract in primary open angle glaucoma: a pilot study. (25319729)
Jabbarpoor Bonyadi M.H.... Saadat S.
|3|ADRB1 and ADBR2 gene polymorphisms and the ocular hypotensive response to topical betaxolol in healthy Mexican subjects. (24749907)
Messina Baas O.... Cuevas-Covarrubias S.A.
|4|Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertension. (21794845)
Williams R.D.... Kopczynski C.
|5|Ocular hypotension and hypotony in multibacillary leprosy patients; at diagnosis, during and after completion of multidrug therapy. (21434594)
Daniel E.... Courtright P.
|6|Morphine-induced ocular hypotension is modulated by nitric oxide and carbon monoxide: role of mu3 receptors. (20148660)
Stagni E.... Drago F.
|7|Ocular hypotensive efficacy and safety of travoprost 0.004% in inadequately controlled primary open-angle glaucoma or ocular hypertension: short-term, multicenter, prospective study. (19210139)
Blini M.... Ratiglia R.
|8|Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow. (19234340)
Woodward D.F.... Krauss A.H.
|9|Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes. (18992242)
Sharif N.A.... Camras C.
|10|Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema? (18460537)
Chang J.H.... Lightman S.
|11|Serotonin-2 (5-HT2) receptor-mediated signal transduction in human ciliary muscle cells: role in ocular hypotension. (17238805)
Sharif N.A.... Davis T.L.
|12|Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension. (16968567)
|13|Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study. (17056362)
Herman D.C.... Kass M.A.
|14|Fadolmidine-induced ocular hypotension in normotensive rabbits. (15720782)
Savolainen J.... JAorvinen T.
|15|Ocular hypotensive effect and safety of brinzolamide ophthalmic solution in open angle glaucoma patients. (15216404)
Wang T.H.... Chen Y.F.
|16|Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. (15037111)
Takagi Y.... Hara H.
|17|Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. (14733708)
Sharif N.A.... Xu S.X.
|18|New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents. (14646172)
Nakajima T.... Hara H.
|19|Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. (12676887)
May J.A.... Dean T.R.
|20|Cystoid macular edema in the era of ocular hypotensive lipids. (11915838)
Wand M.... Shields B.M.
|21|Mechanism of exercise-induced ocular hypotension. (10102302)
Martin B.... Malinovsky V.
|22|Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. (9851310)
Pate D.W.... JAorvinen T.
|23|Lisuride acts at multiple sites to induce ocular hypotension and mydriasis. (9742290)
Potter D.E.... Chu T.C.
|24|Ocular hypotension induced by intravitreally injected C-type natriuretic peptide. (9533834)
Takashima Y.... Yoshimura N.
|25|Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrine. (9436152)
Chu T.C.... Potter D.E.
|26|Ocular hypotensive effect of topical ketanserin in timolol users. (9085107)
Mastropasqua L.... Costagliola C.
|27|Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors. (8921215)
Chu T.C.... Potter D.E.
|28|Evaluation of IBMX-enhanced ocular hypotension after adrenergic agonists in the rabbit eye. (7542619)
Busch M.J.... Hoyng P.F.
|29|Molecular characterization and ocular hypotensive properties of the prostanoid EP2 receptor. (8590276)
Woodward D.F.... Andrews S.W.
|30|Centrally mediated ocular hypotension: potential role of imidazoline receptors. (7677360)
Campbell W.R.... Potter D.E.
|31|Ocular hypotension during short- and long-term hypocapnia. (19920601)
Harris A.... Martin B.J.
|32|Long-term visual outcome of ocular hypotension after thermosclerostomy. (8488912)
Hovanesian J.A.... Musch D.C.
|33|PhXA34-induced ocular hypotension. (1463535)
|34|Dexmedetomidine-induced ocular hypotension in rabbits with normal or elevated intraocular pressures. (1349879)
Vartiainen J.... Virtanen R.
|35|Reattachment of the detached ciliary body with suturing for treatment of contusional ocular hypotension. (1896179)
Zheng Y.Z.... Ji X.C.
|36|Soluble forms of isobutylmethylxanthine enhance the ocular hypotension induced by catecholamines. (1722476)
Busch M.J.... Hoyng P.F.
|37|The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys. (2322152)
Wang R.F.... Sugrue M.F.
|38|Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey. (2737263)
Nilsson S.F.... Stjernschantz J.
|39|Sustained decreases in systemic blood pressure do not cause ocular hypotension. (2710496)
Woodward D.F.... Ruiz G.
|40|Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha. (3477218)
Crawford K.... Kaufman P.L.
|41|Effect of pilocarpine in ocular hypotension. (3982788)
Korczyn A.D.... Goya V.
|42|Inflow and outflow relations after intraocular fluid-Healon exchange in a case of chronic ocular hypotension. (4086174)
Koerner F.... KAPnig H.
|43|Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol. (6098513)
Colasanti B.K.... Craig C.R.
|44|Mature secondary cataracts and reversible ocular hypotension. (6992009)
|45|Effect of vehicle on pilocarpine-induced ocular hypotension. (735763)
Saari M.... Masar S.E.
|46|Possibility of isoproterenol therapy with soft contact lenses: ocular hypotension without systemic effects. (962259)
Bietti G.... Motolese E.
|47|The recovery phase after ocular hypotension induced by compression. (5542865)
Schimek R.A.... Steigner J.B.
|48|Dose response analysis of pilocarpine-induced ocular hypotension. (5478886)
Harris L.S.... Galin M.A.
|49|Ocular hypotension in a population survey. (5359506)
Perkins E.S.... Burau J.
|50|Ocular hypotension with glycerol in cataract surgery. (5222692)